There are some limitations of our study, first of all, whether rapamycin can affect the apoptosis of ovarian cancer cells by targeting GAS5 expression and how to participate in GAS5 target gene (E2F4 or PARP1) regulation need to be further studied. This evidence concerns the gene PARP1 and ovarian carcinoma.